Development deals

Biotech

Sanofi makes $75M preclinical bet to join busy Parkinson's field

The Big Pharma has claimed a spot toward the back of the pack by paying $75 million upfront for the global rights to a preclinical bispecific.
Nick Paul Taylor Jan 12, 2022 8:45am

Amgen teams up with Arrakis in $75M RNA-destroying research deal

Jan 11, 2022 9:00am

Pfizer locks in 2 partners to solidify status as mRNA powerhouse

Jan 10, 2022 6:50am

Verily links up with Sosei Heptares for GPCR drug discovery

Jan 6, 2022 3:30pm

Pfizer, BioNTech team up against GSK's Shingrix dominance

Jan 5, 2022 9:49am

Novartis pays UCB $150M to join Roche in Parkinson's race

Dec 2, 2021 8:00am